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microorganisms, cells and animals to make useful proteins’. 
However, in their final expanded, revised and updated form 
they succeed in providing a worthwhile contribution to the 
current understanding of this aspect of biotechnology. This 
book discusses the nature and importance of the production 
of therapeutically useful proteins in greater depth than the 
general books on biotechnology on the market and thus will 
be helpful in providing a comparatively recent ‘state of the 
art’ picture for research workers in this field. Although osten- 
sibly a specialised book it will also be useful to final year 
undergraduates as a reference source for some of the apphca- 
tions of genetic engineering. Although the index is rather 
limited for a book of this depth of content, there is a useful 
table of contents and the individual chapters are well 
documented. 
There are three main areas of subject material in this book: 
microbial systems and mammalian systems for protein pro- 
duction and thirdly the discovery, design and usage of pro- 
teins as therapeutic agents. It is of considerable interest that 
yeast systems are now being used successfully in the produc- 
tion of proteins for clinical use, such as human serum albumin 
(HSA) and this is discussed in chapter 5. Chapter 3 describes 
the development of vaccines, in particular against the human 
hepatis B virus by the expression of the viral surface antigen 
protein (HBsAg) in transformed yeast. The use of yeast secre- 
tion vectors to express the domains (modules) of mosaic pro- 
teins, such as those from the blood clotting pathway, with 
secretion directly into the extracellular medium is examined in 
chapter 4. 
Tissue-type plasminogen activator (t-PA) is a protein of 
great therapeutic potential. It activates plasminogen to the 
plasmin required to lyse the blood clots, in the coronary 
artery, that are a contributory factor to acute myocardial in- 
farction. The expression of t-PA and related enzymes in mam- 
malian cells is discussed in chapters 6 and 8 and the 
remarkable possibility of producing t-PA in the milk of tran- 
sgenic animals is examined in chapter 11. 
Proteins are amongst the largest drugs used and in contrast 
to most therapeutic agents a protein molecule is not fully 
defined by its ‘chemical formula’. This is because the tertiary 
structure can not as yet be fully predicted from the known 
amino acid sequence. The potential and problems of proteins 
as therapeutic agents and their selective delivery and targeting 
are the subjects of chapters 17 and 16, respectively. In chapter 
14 the importance of recombinant receptor protein analysis in 
the rational design of drugs at the molecular level is debated. 
This interesting book clearly indicates the great potential 
and diversity of the production of therapeutically useful pro- 
teins by biotechnology. These include insulin, growth hor- 
mone, HSA, HBsAg, t-PA and erythropoietin (chapter 15), 
which are now available through the powerful methods of 
biotechnology as applied to a variety of microbial and mam- 
malian cellular systems. 
Helen Wiseman 
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This laboratory manual, spirally bound so that it lies flat on 
the bench and with a very arty cover, is a condensed version 
of the extremely weighty Current Protocols in Molecular 
Biology. A comparison of the two quickly reveals that they 
contain essentially the same set of recipes. What this new ver- 
sion lacks is the italics present in Current Protocols explaining 
why a particular step is of importance. For example, the 
description of how to make RNA from animal tissue is iden- 
tical but you are not told in the Short Protocols why Sarkosyl 
is excluded from the homogenisation step (a frothy mess will 
result!). Having reviewed and used Current Protocols I think 
that this is a pity as an understanding of the potential pitfalls 
of a technique is a key part of using it successfully. All of the 
standard techniques of molecular biology are covered in the 
book with the exception of the polymerase chain reaction 
which is mentioned but not in anything like the detail which 
its widespread use these days would warrant. I found this a 
curious oversight particularly when this series is supposed to 
be updated on a quarterly basis; in 1989 (when it was publish- 
ed) which lab did not have a PCR machine? Like its parent 
volume, Short Protocols is an easy book to use and has some 
of the same clear diagrams. It contains a useful glossary and 
recipe section and a limited, but worthwhile reference section. 
Short Protocols is, as it claims to be, a book designed for 
those who are familiar with the principles but want the basic 
steps. I cannot really see the circumstances under which 
anyone would want to have both of these books but either of 
them would make a useful contribution to the lab. I have to 
say that f31.65 is rather expensive for a spirally bound book 
but it is still one-third of the price of Current Protocols. 
Keith Dudley 
Cellular and Molecular Biology of Muscle Development; Edited by L.H. Kedes and F.E. Stockdale; Alan R. Liss; 
New York, 1989; xxxv + 1059 pages, $195.00. 
Sometimes the grass is greener in the neighbouring scientific 
plot though I cannot pretend to have found it so in the case 
of muscle developmental biology. The field used to resemble 
a bog. This book shows that the scene has changed: there are 
decent islands of firm ground, patches of green are appearing. 
This is primarily due to the application of molecular genetics, 
434 
